SOLV Solventum Corporation
$85.81▲ +0.47%
Healthcare
Other
Volume 975.6K
Avg Volume (10D) 1.02M
Key Metrics & Fundamentals
Market Cap
$14.61B
P/E Ratio
10.5
Div Yield
0.00%
52W Range
62.38 - 94.16
% vs 50 MA
-3.06%
% vs 200 MA
9.48%
RSI-14
44.7
MACD Histogram
-0.0500
Beta (1Y vs SPY)
0.57
Free Cash Flow
$144.00M
Gross Rev
$2.21B
Gross Profit
$1.29B
EBITDA
$305.00M
COGS
$923.00M
Operating Exp
$1.11B
Operating Income
$181.00M
EBIT
$181.00M
Pretax Income
$108.00M
Net Income
$92.00M
EPS (Diluted)
0.53
Price & Volume History
Loading chart…
Recent News
2 cash-burning stocks for long-term investors and 1 we turn down
StockStory · Oct 23, 2026 2:00 PM ET
SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy
Zacks · Oct 23, 2026 11:19 AM ET
Mexico Prefabricated Crown and Bridge Materials Market Outlook to 2036: Permanent Crowns and Bridges Revenue, Volume and Pricing
GlobeNewswire · Oct 22, 2026 9:14 AM ET
Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates
Zacks · Oct 21, 2026 6:25 AM ET
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
PR Newswire · Oct 19, 2026 4:05 PM ET
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
PR Newswire · Oct 15, 2026 4:05 PM ET
Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?
Zacks · Oct 8, 2026 11:10 AM ET
Rothschild & Co Redburn Adjusts Price Target on Solventum to $75 From $70, Maintains Sell Rating
MT Newswires · Oct 6, 2026 7:33 AM ET
3 Overrated Stocks We Approach with Caution
StockStory · Oct 2, 2026 4:14 AM ET
2 Profitable Stocks for Long-Term Investors and 1 We Question
StockStory · Sep 29, 2026 6:08 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SOLV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.